The influence of charge clustering on the anti-HIV-1 activity and in vivo distribution of negatively charged albumins

被引:6
作者
Beljaars, L
Floris, R
Berkhout, B
Smit, C
Meijer, DKF
Molema, G
机构
[1] Univ Groningen, Inst Drug Explorat, GUIDE, Dept Pharmacokinet & Drug Delivery,Ctr Pharm, NL-9713 AV Groningen, Netherlands
[2] NIZO Food Res, Dept Prod Technol, Ede, Netherlands
[3] Univ Amsterdam, Acad Med Ctr, Dept Human Retrovirol, NL-1105 AZ Amsterdam, Netherlands
[4] Univ Groningen, Inst Drug Explorat, GUIDE,Dept Pathol & Lab Med, Tumor Immunol Lab,Med Biol Sect, NL-9713 AV Groningen, Netherlands
关键词
HIV; polyanions; Suc-HSA; structure; heparin; entry inhibitor;
D O I
10.1016/S0006-2952(02)00912-7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The substitution of human serum albumin with negatively charged molecules, such as succinic acid (Suc-HSA) or aconitic acid (Aco-HSA), resulted in proteins with potent anti-HIV activities, by binding to viral gp120 (V3 loop). The aim of the present study was to investigate whether the distribution of negative charges on the albumin backbone influences the anti-HIV activity. Therefore, we prepared albumins with clusters of negatively charged groups by coupling of heparin. The effects of this substitution on anti-HIV activity, in vivo distribution and the protein structure as compared to random succinylation were assessed. In vitro studies indicated that HSA-modified with heparin 6 or 13 kD displayed anti-HIV activity (IC50 = 660 and 37 nM, respectively) and exhibited affinity for gp120-V3 loop, although the activity was lower than that of Suc-HSA. Combined derivatization of HSA with heparin 13 kD and aconitic acid groups resulted in significantly increased inhibitory actions (IC50 = 2.8 nM). Structural analysis showed that modification of HSA with heparin did not lead to extensive unfolding of the protein, meaning that these modified proteins were still globular in structure. In contrast, succinylation of HSA resulted in a highly randomly coiled conformation. Dynamic light scattering experiments revealed that, at neutral pH, the heparin fragments attached to the protein were wrapped around the molecule rather than sticking out into the solution. In conclusion, coupling of sufficient clustered negative charges, by coupling of Hep-fragments, on HSA resulted in a clear anti-HIV activity of the protein. Yet, random distribution of anionic groups in the albumin seemed more optimal for in vitro anti-HIV activity. The higher plasma and lymphatic concentrations of Hep-HSA compared to Suc-HSA seemed more favorable for an anti-HIV activity in vivo. (C) 2002 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:1663 / 1673
页数:11
相关论文
共 32 条
  • [11] DETERMINATION OF FREE AMINO GROUPS IN PROTEINS BY TRINITROBENZENESULFONIC ACID
    HABEEB, AFS
    [J]. ANALYTICAL BIOCHEMISTRY, 1966, 14 (03) : 328 - &
  • [12] Heparin and its derivatives bind to HIV-1 recombinant envelope glycoproteins, rather than to recombinant HIV-1 receptor, CD4
    Harrop, HA
    Rider, CC
    [J]. GLYCOBIOLOGY, 1998, 8 (02) : 131 - 137
  • [13] JANSEN RW, 1993, MOL PHARMACOL, V44, P1003
  • [14] A MODIFIED METHOD FOR COLORIMETRIC DETERMINATION OF HEPARIN
    JAQUES, LB
    WOLLIN, A
    [J]. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1967, 45 (05) : 787 - &
  • [15] Anti-HIV-1 activity of combinations and covalent conjugates of negatively charged human serum albumins (NCAs) and AZT
    Kuipers, ME
    Swart, PJ
    Witvrouw, M
    Esté, JA
    Reymen, D
    De Clercq, E
    Meijer, DKF
    [J]. JOURNAL OF DRUG TARGETING, 1999, 6 (05) : 323 - 335
  • [16] Mechanism of anti-HIV activity of negatively charged albumins: Biomolecular interaction with the HIV-1 envelope protein gp120
    Kuipers, ME
    Huisman, JG
    Swart, PJ
    deBethune, MP
    Pauwels, R
    Schuitemaker, H
    DeClercq, E
    Meijer, DKF
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1996, 11 (05): : 419 - 429
  • [17] Mechanism of anti-HIV activity of succinylated human serum albumin
    Kuipers, ME
    Berg, HVD
    Swart, PJ
    Laman, JD
    Meijer, DKF
    Kopelman, MHGM
    Huisman, H
    [J]. BIOCHEMICAL PHARMACOLOGY, 1999, 57 (08) : 889 - 898
  • [18] HIV fusion and its inhibition
    LaBranche, CC
    Galasso, G
    Moore, JP
    Bolognesi, DP
    Hirsch, MS
    Hammer, SM
    [J]. ANTIVIRAL RESEARCH, 2001, 50 (02) : 95 - 115
  • [19] A GENERAL-METHOD FOR THE DETECTION AND MAPPING OF SUBMICROGRAM QUANTITIES OF GLYCOSAMINOGLYCAN OLIGOSACCHARIDES ON POLYACRYLAMIDE GELS BY SEQUENTIAL STAINING WITH AZURE-A AND AMMONIACAL SILVER
    LYON, M
    GALLAGHER, JT
    [J]. ANALYTICAL BIOCHEMISTRY, 1990, 185 (01) : 63 - 70
  • [20] DRUG TARGETING SYSTEMS FOR ANTIVIRAL AGENTS - OPTIONS AND LIMITATIONS
    MEIJER, DKF
    JANSEN, RW
    MOLEMA, G
    [J]. ANTIVIRAL RESEARCH, 1992, 18 (3-4) : 215 - 258